Author/Creator: Wada, Russ - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Wada, Russ

1. Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study. (19th December 2018)

Authors:: Kirschbrown, Whitney P.; Wynne, Chris; Kågedal, Matts; Wada, Russ; Li, Hanbin; Wang, Bei; Nijem, Ihsan; Badovinac Crnjevic, Tanja; Gasser, Helena; Heeson, Sarah; Eng‐Wong, Jennifer; Garg, Amit
Journal:: Journal of clinical pharmacology
Issue:: Volume 59:Number 5(2019)
Page Start:: 702
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Exposure‐Response Relationships in Patients With HER2‐Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan. Issue 4 (10th June 2021)

Authors:: Yin, Ophelia; Iwata, Hiroji; Lin, Chia‐Chi; Tamura, Kenji; Watanabe, Junichiro; Wada, Russ; Kastrissios, Helen; AbuTarif, Malaz; Garimella, Tushar; Lee, Caleb; Zhang, Lin; Shahidi, Javad; LaCreta, Frank
Journal:: Clinical pharmacology & therapeutics
Issue:: Volume 110:Issue 4(2021)
Page Start:: 986
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Exposure–Response‐Based Product Profile–Driven Clinical Utility Index for Ipatasertib Dose Selection in Prostate Cancer. (6th March 2019)

Authors:: Zhu, Rui; Poland, Bill; Wada, Russ; Liu, Qi; Musib, Luna; Maslyar, Daniel; Cho, Eunpi; Yu, Wei; Ma, Han; Jin, Jin Yan; Budha, Nageshwar
Journal:: CPT: pharmacometrics & systems pharmacology
Issue:: Volume 8:Number 4(2019)
Page Start:: 240
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Population pharmacokinetic and exposure‐response analyses of ivosidenib in patients with IDH1‐mutant advanced hematologic malignancies. Issue 3 (25th January 2021)

Authors:: Jiang, Xuemin; Wada, Russ; Poland, Bill; Kleijn, Huub Jan; Fan, Bin; Liu, Guowen; Liu, Hua; Kapsalis, Stephanie; Yang, Hua; Le, Kha
Journal:: Clinical and translational science
Issue:: Volume 14:Issue 3(2021)
Page Start:: 942
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Population Pharmacokinetics of Trastuzumab Deruxtecan in Patients With HER2‐Positive Breast Cancer and Other Solid Tumors. Issue 5 (6th December 2020)

Authors:: Yin, Ophelia; Xiong, Yuan; Endo, Seiko; Yoshihara, Kazutaka; Garimella, Tushar; AbuTarif, Malaz; Wada, Russ; LaCreta, Frank
Journal:: Clinical pharmacology & therapeutics
Issue:: Volume 109:Issue 5(2021)
Page Start:: 1314
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer. Issue 1 (21st November 2019)

Authors:: Shemesh, Colby S.; Chanu, Pascal; Jamsen, Kris; Wada, Russ; Rossato, Gianluca; Donaldson, Francis; Garg, Amit; Winter, Helen; Ruppel, Jane; Wang, Xin; Bruno, Rene; Jin, Jin; Girish, Sandhya
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 7:Issue 1(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗